CR7441A - MICROGLY INHIBITORS TO INTERRUPT IMMUNE REACTIONS ASSOCIATED WITH INTERLEUCINE 12 AND IFNY - Google Patents

MICROGLY INHIBITORS TO INTERRUPT IMMUNE REACTIONS ASSOCIATED WITH INTERLEUCINE 12 AND IFNY

Info

Publication number
CR7441A
CR7441A CR7441A CR7441A CR7441A CR 7441 A CR7441 A CR 7441A CR 7441 A CR7441 A CR 7441A CR 7441 A CR7441 A CR 7441A CR 7441 A CR7441 A CR 7441A
Authority
CR
Costa Rica
Prior art keywords
inhibitors
microgly
interleucine
ifny
interrupt
Prior art date
Application number
CR7441A
Other languages
Spanish (es)
Inventor
Thorsten Blume
Wolf-Dietrich Docke
Wolfang Halfbrodt
Joachim Kuhnke
Ursula Monning
Bernd Elger
Herbert Schneider
Original Assignee
Shering Artiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shering Artiengesellschaft filed Critical Shering Artiengesellschaft
Priority to CR7441A priority Critical patent/CR7441A/en
Publication of CR7441A publication Critical patent/CR7441A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Uso de inhibidores de la microglia para preparar farmacos que inhiben las reacciones inmunes asociadas con monocitos, macrofagos y celulas- T y su uso para el tratamiento de enfermdedades inmunologicas asociadas con celulas- T y reacciones inflamatorias no asociadas con celulas-T.Use of microglia inhibitors to prepare drugs that inhibit immune reactions associated with monocytes, macrophages and T-cells and their use for the treatment of immunological diseases associated with T-cells and inflammatory reactions not associated with T-cells.

CR7441A 2004-09-01 2004-09-01 MICROGLY INHIBITORS TO INTERRUPT IMMUNE REACTIONS ASSOCIATED WITH INTERLEUCINE 12 AND IFNY CR7441A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR7441A CR7441A (en) 2004-09-01 2004-09-01 MICROGLY INHIBITORS TO INTERRUPT IMMUNE REACTIONS ASSOCIATED WITH INTERLEUCINE 12 AND IFNY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR7441A CR7441A (en) 2004-09-01 2004-09-01 MICROGLY INHIBITORS TO INTERRUPT IMMUNE REACTIONS ASSOCIATED WITH INTERLEUCINE 12 AND IFNY

Publications (1)

Publication Number Publication Date
CR7441A true CR7441A (en) 2006-02-06

Family

ID=44839230

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7441A CR7441A (en) 2004-09-01 2004-09-01 MICROGLY INHIBITORS TO INTERRUPT IMMUNE REACTIONS ASSOCIATED WITH INTERLEUCINE 12 AND IFNY

Country Status (1)

Country Link
CR (1) CR7441A (en)
  • 2004

Similar Documents

Publication Publication Date Title
CL2008002207A1 (en) Pharmaceutical composition comprising immunosuppressants to improve the effect in the use of an antagonist of interleukin-6 (il-6) for the treatment of illnesses related to il-6 (div. Sol. 896-04).
CL2007001996A1 (en) Compounds derived from phenyl substituted nitrogen heteroaryls, inhibitors of cytokine production; pharmaceutical composition that includes them; and its uses in the treatment of cancer, infections, inflammatory and autoimmune diseases.
SA520411202B1 (en) Cytokine conjugates for the treatment of autoimmune diseases
UY27662A1 (en) MOCROGLY INHIBITORS TO INTERRUPT IMMUNE REACTIONS ASSOCIATED WITH INTERLEUCINE 12 AND IFNY.
UY27720A1 (en) MONOCYCLIC AROILPIRIDINONES,
CL2008002852A1 (en) Compounds derived from 7-fluoro-5-methyl-2- (phenylamino) -6,7,8,9-tetrahydro-5h-pyrimido [4,5-b] [1,4] diazepin-6 (7h) -one ; pharmaceutical composition comprising said compounds; and its use in the treatment of cancers, inflammation, alopecia, autoimmune, cardiovascular, infectious, nephrological, neurodfegenerative, skin and bone diseases.
CL2011000301A1 (en) Compounds derived from purine with immunomodulatory activity; pharmaceutical composition comprising them; and use of them in the treatment of allergic diseases, allergic rhinitis, asthma, infectious diseases and cancer.
MXPA03008955A (en) Remedies for infant chronic arthritis-relating diseases.
CR7786A (en) NEUTRALIZING ANTIBODIES AGAINST GDF-8 AND THE USE OF THE SAME
ATE466085T1 (en) PROTEASE-RESISTANT MODIFIED INTERFERON ALPHA POLYPEPTIDES
ES2154741T3 (en) USE OF CD23 UNION AGENTS IN THE TREATMENT OF AUTOIMMUNE DISEASES.
PT2126054T (en) GENETICALLY MODIFIED, REDIRECTED REGULATORY T-CELLS AND THEIR USE IN THE SUPPRESSION OF INFLAMMATORY AND AUTOIMMUNITY DISEASES
MEP18208A (en) Immune response modifier foam formulations
BRPI0511477A (en) compounds and compositions as modulators of ppar
GT200500363A (en) 3-AMINO-PIRAZOL [3,4B] PIRIDINES WITH PROTEINTIROSINKINASE INHIBITORS, THEIR PREPARATION AND USE AS A MEDICINAL PRODUCT.
ZA202203254B (en) Immunocytokine comprising heterodimeric protein complex based on il-15/il-15rα
AR048963A1 (en) POLOXAMERO HYDROGEL INTERFER FORMULATIONS
UY28080A1 (en) POSITIONAL ISOMERS OF IFN PEG ALFA 2A
CL2003002678A1 (en) COMPOUNDS DERIVED FROM PIPERIDINE, RECRUITOR ACTIVITY MODULATORS CCR5; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION, AND ITS USE IN THE TREATMENT OF IMMUNOLOGICAL, INFLAMMATORY DISEASES, ASTHMA, Rheumatoid Arthritis and Atheroscle
AR040130A1 (en) ETONOGESTREL ESTERES, ITS USE AS ANTICOPCEPTIVE AND FOR THE TREATMENT OF GYNECOLOGICAL DISORDERS
TW200531679A (en) Methods of modulating cytokine activity; related reagents
UY27275A1 (en) COMPOSITIONS AND METHODS TO INCREASE THE BIODISPONIBILITY OF PHARMACEUTICAL AGENTS
EP1578373A4 (en) NEW COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH THE IMMUNE SYSTEM
CR7441A (en) MICROGLY INHIBITORS TO INTERRUPT IMMUNE REACTIONS ASSOCIATED WITH INTERLEUCINE 12 AND IFNY
ATE431742T1 (en) MODIFIED CYTOKINE FOR CANCER THERAPY

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)